HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate Offers 'Anti-Aging' Toothpaste In China, Ready For 'Prolonged' Coronavirus

Executive Summary

Colgate expects a ‘modest negative impact’ from the coronavirus on its first quarter results, but it made contingency plans for longer-term impact. In a presentation at the CAGNY conference, CEO Noel Wallace discussed a new anti-aging toothpaste in China and the latest iteration of Colgate Optic White in the US.

You may also be interested in...



PCPC Leads Off Annual Meeting With Coronavirus Remarks: “A Significant New World Overnight”

Coronavirus was a factor in attendance of the Personal Care Products Council’s 2020 annual meeting in Palm Beach, FL. Opening the conference on 2 March, chairman George Calvert, chief supply chain officer at Amway, discussed with CEO Lezlee Westine the epidemic’s ongoing impact on supply networks and global cosmetics business.

HBW Product Launches: VitaFusion Goodness, Colgate Zero, Tom’s Prebiotic, Gaia Hemp & Herb

Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.

Coronavirus Drives TCM Sales In China, Clouds Global Consumer Health Outlook

Consumer health product firms say the coronavirus will have an impact on their results, but it’s too early to estimate the costs. US FDA also hedges its predictions, saying the outbreak could lead to interruptions in country’s drug and medical device supplies. China's health commission has issued six guidelines for diagnosis and treatment, but no conventional antiviral treatment is approved and it's emphasizing traditional Chinese medicines.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149731

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel